腸溶軟膠囊市場規模、佔有率及成長分析（依產品類型、原料、通路、應用、最終用戶及地區）－2025-2032 年產業預測

2023 年全球腸溶軟膠囊市場規模為 24 億美元，預計將從 2024 年的 25 億美元成長到 2032 年的 34.5 億美元，預測期內（2025-2032 年）的複合年成長率為 4.1%。

腸溶軟膠囊市場預計將顯著成長，因為消費者對預防醫學益處的認知不斷提高、老年人口不斷成長以及慢性病和營養不良的流行。腸溶軟膠囊是一種用於半固態和液體藥物的明膠包衣軟膠囊。隨著人們健康意識的增強，膳食補充劑也越來越受到認可，進一步推動了需求。值得注意的是，創新的非明膠產品正在湧現，以滿足素食消費者的需求，利用澱粉和植物來源成分來增加市場吸引力。此外，電子商務平台的擴張和領先公司為提高膠囊的生物利用度而活性化的研發投入可能會對市場動態正面影響。可咀嚼軟膠囊不需用水服用，預計未來幾年將提升市場前景。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 二次資料和一次資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024年）
• PESTEL分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

腸溶軟膠囊市場規模（依產品類型及複合年成長率）（2025-2032）

• 市場概覽
• 明膠軟膠囊
• 素食軟膠囊

腸溶軟膠囊市場規模（按原料及複合年成長率） (2025-2032)

• 市場概覽
• A型明膠（豬皮）
• B型明膠（動物骨骼和皮膚）
• 魚骨明膠
• 纖維素衍生物
• 澱粉類物質

腸溶軟膠囊市場規模（依分銷管道分類）及複合年成長率（2025-2032）

• 市場概覽
• 超級市場和大賣場
• 藥局和藥局
• 線上提供者

腸溶軟膠囊市場規模（依應用）及複合年成長率（2025-2032）

• 市場概覽
• 制酸劑和腸道調節劑
• 抗發炎藥物
• 抗生素和抗菌劑
• 咳嗽和感冒藥
• 健康補充品
• 維生素和營養補充劑
• 其他治療用途

腸溶軟膠囊市場規模（依最終用戶分類）及複合年成長率（2025-2032）

• 市場概覽
• 製藥公司
• 營養補充品公司
• 化妝品公司
• 食品工業

腸溶軟膠囊市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024年）
• 主要企業簡介
  • 公司詳情
  • 產品系列分析
  • 公司分部佔有率分析
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• BASF SE（Germany）
• Colorcon Inc.（United States）
• Fuji Capsule Co., Ltd.（Japan）
• Lonza Group AG（Switzerland）
• Now Health Group Inc.（United States）
• ProCaps Group（Luxembourg）
• Super Spectrim（United States）
• Thermo Fisher Scientific Inc.（United States）
• Key Developments
• Sirio Pharma Co., Ltd.（China）
• Soft Gel Technologies, Inc.（United States）
• EuroCaps Ltd.（United Kingdom）
• Geltec Pvt. Ltd.（India）
• Captek Softgel International, Inc.（United States）
• Elnova Pharma（Canada）
• Best Formulations（United States）
• Pharmavite LLC（United States）
• Robinson Pharma, Inc.（United States）

結論和建議

Global Enteric Softgel Market size was valued at USD 2.4 billion in 2023 and is poised to grow from USD 2.5 billion in 2024 to USD 3.45 billion by 2032, growing at a CAGR of 4.1% during the forecast period (2025-2032).

The market for enteric softgel capsules, which feature gelatin-based coatings for semi-solid and liquid medications, is poised for significant growth, driven by increasing consumer awareness of preventive medicine benefits, a rising geriatric population, and the prevalence of chronic and nutrient deficiency diseases. As health consciousness grows, so does the acceptance of dietary supplements, further fueling demand. Notably, innovative non-gelatin variants catering to vegan consumers are emerging, utilizing starch and plant-based sources to enhance market appeal. Additionally, the expansion of e-commerce platforms and heightened R&D investments by major players aimed at improving capsule bioavailability are set to positively influence market dynamics. Chewable softgel options that require no water to consume are anticipated to boost market prospects in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Enteric Softgel market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Enteric Softgel Market Segments Analysis

Global Enteric Softgel Market is segmented by Product Type, Raw Material, Distribution Channel, Application, End User and region. Based on Product Type, the market is segmented into Gelatin Softgel Capsules and Vegetarian Softgel Capsules. Based on Raw Material, the market is segmented into Type-A Gelatin (Pork Skin), Type-B Gelatin (Animal Bones and Skin), Fish Bone Gelatin, Cellulose Derivatives and Starch Material. Based on Distribution Channel, the market is segmented into Supermarket and Hypermarket, Pharmacy and Drug store and Online Provider. Based on Application, the market is segmented into Antacid and Antiflatulent Preparations, Anti-inflammatory Drugs, Antibiotic and Antibacterial Drugs, Cough and Cold Preparations, Health Supplements, Vitamin and Dietary Supplements and Other Therapeutic Applications. Based on End User, the market is segmented into Pharmaceutical Companies, Nutraceutical Companies, Cosmeceutical Companies and Food Industry. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Enteric Softgel Market

The global enteric softgel market is primarily driven by a surge in investments aimed at enhancing the bioavailability of these capsules. Notably, leading companies are ramping up production to satisfy the growing demand for health-focused nutritional supplements. For instance, Catalent Pharma Solutions, a prominent American player, recently announced plans to invest over USD 5 million in a new drug development center located in Somerset, New Jersey. This investment is expected to bolster the company's capabilities in capsule coating technology, thereby strengthening its position within the enteric softgel market. As advanced manufacturing techniques are developed and major players focus on improving efficiency, the market is set to witness increased productivity and reduced complexity in drug development processes.

Restraints in the Global Enteric Softgel Market

The global enteric softgel market faces significant challenges related to the stability and shelf-life of these capsules. Consumers often encounter issues when storing enteric softgels for more than six months, leading to concerns about their efficacy. Moreover, the inherent dynamic nature of these capsules complicates efforts for manufacturers to enhance both their shelf-life and chemical stability. As a result, this limitation can hinder widespread adoption and consumer confidence in enteric softgel products, posing a notable restraint on market growth and innovation. Addressing these stability issues will be crucial for advancing the market potential of enteric softgel capsules.

Market Trends of the Global Enteric Softgel Market

The Global Enteric Softgel market is experiencing a notable shift towards vegan alternatives, driven by the rising trend of veganism and growing consumer awareness regarding animal welfare and health impacts associated with traditional gelatin-based capsules. As more consumers adopt vegetarian and vegan lifestyles, demand for plant-based enteric softgel options is expected to increase significantly. This paradigm shift is compelling manufacturers to innovate and reformulate products, utilizing ingredients such as hydroxypropyl methylcellulose and other plant-derived substances. Market dynamics are thus evolving, with a focus on sustainability and health-conscious choices poised to define the future landscape of the enteric softgel industry.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Enteric Softgel Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Gelatin Softgel Capsules
• Vegetarian Softgel Capsules

Global Enteric Softgel Market Size by Raw Material & CAGR (2025-2032)

• Market Overview
• Type-A Gelatin (Pork Skin)
• Type-B Gelatin (Animal Bones and Skin)
• Fish Bone Gelatin
• Cellulose Derivatives
• Starch Material

Global Enteric Softgel Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Supermarket and Hypermarket
• Pharmacy and Drug store
• Online Provider

Global Enteric Softgel Market Size by Application & CAGR (2025-2032)

• Market Overview
• Antacid and Antiflatulent Preparations
• Anti-inflammatory Drugs
• Antibiotic and Antibacterial Drugs
• Cough and Cold Preparations
• Health Supplements
• Vitamin and Dietary Supplements
• Other Therapeutic Applications

Global Enteric Softgel Market Size by End User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical Companies
• Nutraceutical Companies
• Cosmeceutical Companies
• Food Industry

Global Enteric Softgel Market Size & CAGR (2025-2032)

• North America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • US
  • Canada
• Europe (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Raw Material, Distribution Channel, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Raw Material, Distribution Channel, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Raw Material, Distribution Channel, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• BASF SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Colorcon Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Capsule Co., Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Now Health Group Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ProCaps Group (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Super Spectrim (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
• Key Developments
• Sirio Pharma Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Soft Gel Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EuroCaps Ltd. (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Geltec Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Captek Softgel International, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elnova Pharma (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Best Formulations (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pharmavite LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Robinson Pharma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations